MarketsMOJO Upgrades Nath Bio-Genes (India) to 'Hold' Rating After Strong Quarterly Results

Nath Bio-Genes (India), a microcap company in the agri-seeds industry, has recently been upgraded to a 'Hold' rating by MarketsMOJO. This upgrade comes after the company has declared positive results for the last four consecutive quarters, with a significant growth in both PAT and net sales.
The stock is currently in a mildly bullish range and has shown improvement in its technical trend since March 14, 2024, generating a return of -1.96% since then. The KST and OBV technical factors are also bullish, indicating a positive outlook for the stock.

In terms of valuation, Nath Bio-Genes (India) has a very attractive ROCE of 7 and is trading at a discount compared to its average historical valuations. Additionally, the company's profits have risen by 575.1% in the past year, while the stock has generated a return of 24.50%. This results in a PEG ratio of 0, indicating a potentially undervalued stock.

However, the company does have weak long-term fundamental strength, with an average ROCE of 7.63% and poor growth in net sales and operating profit over the last 5 years. It has also underperformed the market in the last year, with a return of 24.50% compared to the market's return of 36.79%.

Nath Bio-Genes (India) has a majority of non-institutional shareholders, indicating potential interest from retail investors. Overall, while the company's recent performance has been positive, its long-term fundamentals and market performance may warrant a 'Hold' rating for now. Investors should continue to monitor the stock's progress and make informed decisions based on their own research and risk tolerance.